ImmunityBio, Inc. IBRX on Monday received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for the supplemental biologics license application (sBLA) for use of ANKTIVA ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that the Company received a Refusal to File (RTF) letter from the U.S. Food and ...
Shares of Axsome Therapeutics, Inc. (AXSM) slumped 3% in the pre-market session on Monday after the company said that it has received a Refusal-to-File (RTF) letter from the U.S. Food and Drug ...
Shares of ImmunityBio touched a 52-week low after the company received a refusal-to-file letter from the Food and Drug Administration for a supplemental biologics license application for ...
INDIANAPOLIS (WISH) — U.S. representatives from Indiana were among 13 Congress members who wrote a letter to Formula 1 inquiring about its recent decision rejecting a proposal from Andretti Global and ...
Twenty-one civil service employees resigned en masse from Elon Musk's Department of Government Efficiency, according to a letter posted online and shared with media outlets Tuesday. The Hill's Julia ...
I have been dealing with unresolved issues related to St. Louis city property inspections going back to 2014. The issue is related to properties near mine with high weeds growing on, under, through ...
Eight faculty members in the physics department wrote an open letter on April 22 supporting a national statement by the American Association of Colleges and Universities (AAC&U) criticizing ...
ImmunityBio Requests an Urgent Meeting With FDA to Address the Change in the Agency’s Unambiguous Guidance on Jan 2025 to Submit a sBLA for NMIBC BCG Unresponsive Papillary Disease, Following an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback